What is PRC Clinical?
PRC Clinical operates as a specialized Contract Research Organization, delivering high-quality, customized trial management solutions across the United States. With a legacy spanning over two decades, the firm has cultivated deep expertise in managing complex clinical trials for regenerative medicine, pharmaceuticals, biologics, and emerging biotech sectors. Their service portfolio is comprehensive, encompassing study management, electronic Trial Master File (eTMF) systems, document management, rigorous study monitoring, and intricate logistics coordination. By prioritizing streamlined processes and precise enrollment timelines, PRC Clinical functions as a critical partner for sponsors aiming to navigate the regulatory and operational hurdles of modern drug development.
How much funding has PRC Clinical raised?
PRC Clinical has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in PRC Clinical
PPP
Public-Private Partnership
What's next for PRC Clinical?
With the infusion of this late-stage capital, PRC Clinical is poised to scale its infrastructure to meet the increasing demand for specialized CRO services. The strategic focus will likely shift toward enhancing their digital trial management platforms and expanding their logistics network to support more complex, multi-site global studies. As the biotech and pharmaceutical industries continue to prioritize speed-to-market and data integrity, PRC Clinical's commitment to quality-driven trial management positions them as a key player in the next wave of medical innovation. Future growth will likely be driven by deepening sponsor relationships and integrating advanced data analytics into their existing trial management framework.
See full PRC Clinical company page
